Making earlier cancer detection a routine part of medical care

Uniquely positioned to support the two biggest patient needs in residual and recurrent disease Annual MRD testing opportunities by cancer type gastric skin kidney bladder lung EXACT SCIENCES Note: includes annual U.S. addressable populations Source: Exact Sciences estimates colon prostate 328K breast 1.3M Upcoming milestones Initiate additional studies Tumor-naive colon data at ASCO '22 X Tumor-naive breast data at SABCS '22 X Tumor-informed/naive colon data at ASCO GI '23 XFinalize tumor-informed design X Make available as an LDT 11

View entire presentation